Viron Therapeutics Inc
2 clinical trials · Sponsor
◉ Watch Viron Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine (NCT00655395) | Viron Therapeutics Inc | 2008-03-01 |
| Serp-1 for the Treatment of Acute Coronary Syndrome (NCT00243308) | Viron Therapeutics Inc | 2005-10-01 |
Track Viron Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.